Fig. 4From: Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trialEffect on PGA a and BSA b scores in response to etanercept by treatment group (LOCF data). *p < 0.0001. BIW: twice weekly; BSA: body surface area; LOCF: last observation carried forward; PGA: Physician’s Global Assessment; QW: once weeklyBack to article page